Activation of the Aryl Hydrocarbon Receptor by Structurally Diverse Exogenous and Endogenous Chemicals

Annual Review of Pharmacology and Toxicology

Volumn 43, Issue , 2003, Pages 309-334

  Denison, Michael S ^a   Nagy, Scott R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; Ah receptor; Ah receptor ligands; CYP1A1; TCDD

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; ARACHIDONIC ACID DERIVATIVE; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; CAFFEINE; CANTHAXANTHIN; CARBARIL; CIPERMETHRIN; CYTOCHROME P450; DRUG METABOLIZING ENZYME; ENDOGENOUS COMPOUND; ENVIRONMENTAL CHEMICAL; ENZYME ACTIVATOR; HALOGENATED ARYL HYDROCARBON; HALOGENATED HYDROCARBON; INDOLE DERIVATIVE; LIGAND; MEVINOLIN; MYRISTICIN; NATURAL PRODUCT; OMEPRAZOLE; OXFENDAZOLE; OXYSTEROL; POLYCYCLIC AROMATIC HYDROCARBON; PRIMAQUINE; PYRROLE DERIVATIVE; RETINOID; TIABENDAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOBIOTIC AGENT; BIOLOGICAL FACTOR; CYTOCHROME P450 1A1;

ADAPTATION; BINDING SITE; CHEMICAL STRUCTURE; DIETARY INTAKE; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; INVERTEBRATE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; XENOBIOTIC METABOLISM; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; STRUCTURE ACTIVITY RELATION;

INVERTEBRATA; VERTEBRATA;

ANIMALS; BINDING SITES; BIOLOGICAL FACTORS; CYTOCHROME P-450 CYP1A1; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIGANDS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; XENOBIOTICS;

EID: 0038768712     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.43.100901.135828     Document Type: Review

References (173)

1. Hankinson O. 1995. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:307-40
2. Schmidt JV, Bradfield CA. 1996. Ah receptor signaling pathways. Annu. Rev. Cell. Dev. Biol. 12:55-89
3. Denison MS, Elferink CF, Phelan D. 1998. The Ah receptor signal transduction pathway. In Toxicant-Receptor Interactions in the Modulation of Signal Transduction and Gene Expression, ed. MS Denison, WG Helferich, pp. 3-33. Philadelphia: Taylor & Francis
4. Ma Q. 2001. Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor regulation, and expanding biological roles. Curr. Drug Metabol. 2:149-64
5. Whitlock JP Jr. 1999. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39:103-25
6. Denison MS, Seidel SD, Rogers WJ, Ziccardi M, Winter GM, Heath-Pagliuso S. 1998. Natural and synthetic ligands for the Ah receptor. In Molecular Biology Approaches to Toxicology, ed. A Puga, KB Wallace, pp. 393-410. Philadelphia: Taylor & Francis
7. Denison MS, Heath-Pagliuso S. 1998. The Ah receptor: a regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull. Environ. Contam. Toxicol. 61:557-68
8. Poland A, Knutson JC. 1982. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22:517-42
9. Safe S. 1990. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 21:51-88
10. Safe S. 1995. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Therap. 67:247-81
11. Devito MJ, Birnbaum LS. 1994. Toxicology of dioxins and related chemicals. In Dioxins and Health, ed. A Schecter, pp. 139-62. New York: Plenum
12. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA. 1996. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. USA 93:6731-36
13. Femandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. 1996. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140:173-79
14. Thurmond TS, Silverstone AE, Baggs RB, Quimby FW, Staples JE, Gasiewicz TA. 1999. A chimeric aryl hydrocarbon receptor knockout mouse model indicates that aryl hydrocarbon receptor activation in hematopoietic cells contributes to the hepatic lesions induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 158:33-40
15. Meyer BK, Pray-Grant MG, Vanden Heuvel JP, Perdew GH. 1998. Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Molec. Cell. Biol. 18:978-88
16. Kazlauskas A, Poellinger L, Pongratz I. 1999. Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor. J. Biol. Chem. 274:13519-24
17. Hord NG, Perdew GH. 1994. Physiochemical and immunochemical analysis of aryl hydrocarbon receptor nuclear translocator: characterization of two monoclonal antibodies to the aryl hydrocarbon receptor nuclear translocator. Molec. Pharmacol. 46:618-24
18. Pollenz RS, Sattler CA, Poland A. 1994. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunfluorescence microscopy. Molec. Pharmacol. 45:428-38
19. Probst MR, Reisz-Porszasz S, Agbunag RV, Ong MS, Hankinson O. 1993. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Molec. Pharmacol. 44:511-18
20. Roberts BJ, Whitelaw ML. 1999. Degradation of the basic helix-loop-helix/ Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway. J. Biol. Chem. 274:36351-56
21. Denison MS, Fisher JM, Whitlock JP Jr. 1988. The DNA recognition site for the dioxin-Ah receptor complex: nucleotide sequence and functional analysis. J. Biol. Chem. 263:17721-24
22. Bank PA, Yao EF, Phelps CL, Harper PA, Denison MS. 1992. Species-specific binding of transformed Ah receptor to a dioxin responsive transcriptional enhancer. Eur. J. Pharmacol. 258:85-94
23. Holmes JL, Pollenz RS. 1997. Determination of aryl hydrocarbon receptor nuclear translocator protein concentration and subcellular localization in hepatic and nonhepatic cell culture lines: development of quantitative Western blotting protocols for calculation of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein in total cell lysates. Molec. Pharmacol. 52:202-11
24. Hahn ME. 1988. The aryl hydrocarbon receptor: a comparative perspective. Comp. Biochem. Physiol. 121:23-53
25. Gillner M, Bergman J, Cambillau C, Alexandersson M. Fernstro B, Gustafsson J-A. 1993. Interactions of indolo [3,2-b]carbazoles and related polycyclic aromatic hydrocarbons with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Molec. Pharmacol. 44:336-45
26. Kafafi SA, Afeefy HY, Said HK, Kafafi AG. 1993. Relationship between aryl hydrocarbon receptor binding, induction of aryl hydrocarbon hydroxylase and 7-ethyoxyresorufin o-deethylase enzymes and toxic activities of aromatic xenobiotics in animals. A new model. Chem. Res. Toxicol. 6:328-34
27. Waller CL, McKinney JD. 1995. Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization. Chem. Res. Toxicol. 8:847-58
28. Bonati L, Fraschini E, Lasagni M, Modoni EP, Pitea D. 1995. A hypothesis on the mechanism of PCDD biological activity based on molecular electrostatic potential modeling, part 2. J. Mol. Struct. (Theochem.) 340: 83-95
29. Fraschini E, Bonati L, Pitea D. 1996. Molecular polarizability as a tool for understanding the binding properties of polychlorinated dibenzo-p-dioxins: definition of a reliable computational procedure. J. Phys. Chem. 100:10564-69
30. Tuppurainen K, Ruuskanen J. 2000. Electronic eigenvalue (EEVA): a new QSAR/QSPR descriptor for electronic substituent effects based on molecular orbital energies. A QSAR approach to the Ah receptor binding affinity of polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs). Chemosphere 41:843-48
31. Mhin BJ, Lee JE, Choi W. 2002. Understanding the congener-specific toxicity in polychlorinated dibenzo-p-dioxins: chlorination pattern and molecular quadrupole moment. J. Am. Chem. Soc. 124:144-48
32. Nagy SR, Sanborn JR, Hammock BD, Denison MS. 2002. Development of a green fluorescent protein based cell bioassay for the rapid and inexpensive detection and characterization of AhR agonists. Toxicol. Sci. 65:200-10
33. Nagy SR, Liu G, Lam K, Denison MS. 2002. Identification of novel Ah receptor agonists using a high-throughput green fluorescent protein-based recombinant cell bioassay. Biochem. 41:861-68
34. Wattenberg LW, Loub WD. 1978. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res. 38:1410-13
35. Bjeldanes LF, Kim J-L, Grose KR, Bartholomew JC, Bradfield CA. 1991. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA 88:9543-47
36. Gillner M, Bergman J, Cambillau C, Gustafsson JA. 1989. Interactions of rutaecarpine alkaloids with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis 10:651-54
37. MacDonald CJ, Ciolino HP, Yeh GC. 2001. Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P50 1A1, 1A2, and 1B1. Cancer Res. 613919-24
38. Ciolino HP, Daschner PJ, Wang TTY, Yeh GC. 1998. Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol. 56:197-205
39. Gradelet S, Leclerc J, Siess M-H, Astorg PO. 1996. B-Apo-8′ -carotenal, but not β-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 26:909-19
40. Gradelet S, Astorg P, Leclerc J, Chevalier J, Vemevaut M-F, Siess M-H. 1996. Effects of canthaxanthin, astaxanthin, lycopene and lutein on liver xenobiotic-metabolizing enzymes in the rat. Xenobiotica 6:49-63
41. Perdew GH, Babbs CF. 1991. Production of Ah receptor ligands in rat fecal suspensions containing tryptophan or indole-3-carbinol. Nutr. Cancer. 16:209-18
42. Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, Bradlow HL. 1993. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem. Pharmacol. 45:1129-36
43. Ashida H, Fukuda I, Yamashita T, Kanazawa K. 2000. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett. 476:213-17
44. Yannai S, Day AJ, Williamson G, Rhodes MJ. 1998. Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines. Food Chem. Toxicol. 36:623-30
45. Ashida H. 2000. Suppressive effects of flavonoids on dioxin toxicity. Biofactors 12:201-6
46. Allen SW, Mueller L, Williams SN, Quattrochi LC, Raucy J. 2001. The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyplal expression. Drug Metab. Dispos. 29:1074-79
47. Obermeier MT, White RE, Yang CS. 1995. Effects of bioflavonoids on hepatic P450 activities. Xenobiotica 25:575-84
48. Ciolino HP, Daschner PJ, Yeh GC. 1999. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 340:715-22
49. Ciolino HP, Wang TTY, Yeh GC. 1998. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res. 58:2754-60
50. Canivenc-Lavier MC, Vernevaut MF, Totis M, Siess MH, Magdalou J, Suschetet M. 1996. Comparative effects of flavonoids and model inducers on drug- metabolizing enzymes in rat liver. Toxicology 114:19-27
51. Doostdar H, Burke MD, Mayer RT. 2000. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 144:31-38
52. Berhow M, Tisserat B, Kanes K, Vandercook C. 1998. Survey of phenolic compounds produced in citrus. Tech. Bull. No. 1856. U.S. Dept. Agr, Peoria, IL
53. Herzog MG, Hollman PCH, Katan MB. 1992. Content of potentially anticarcinogenic flavonoids of 28 vegetable and 9 fruits commonly consumed in the Netherlands. J. Agr. Food Chem. 41:2379-83
54. Herzog MG, Hollman PCH, van de Putte B. 1993. Content of potentially anticarcinogenic flavonoids of tea infusions, wines and fruit juices. J. Agr. Food Chem. 41:1242-46
55. Formica JV, Regelson W. 1995. Review of the biology of Quercetin and related bioflavonoids. Food Chem. Toxicol. 33:1061-80
56. Paganga G, Rice-Evans CA. 1997. The identification of flavonoids as glycosides in human plasma. FEBS Lett. 401:78-82
57. Nakagawa K, Okuda S, Miyazawa T. 1997. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotechnol. Biochem. 61:1981-85
58. de Vries JH, Hollman PC, Meyboom S, Buysman MN, Zock PL, et al. 1998. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am. J. Clin. Nutr. 68:60-65
59. Bohonowych JE, Rogers JM, Jeuken A, Denison MS. 2000. Activation of Ah and estrogen receptor-based cell bioassay systems by extracts of natural dietary herbal supplements. Organohal. Compd. 45:240-43
60. Amakura Y, Tsutsumi T, Nakamura M, Kitagawa H, Fuijino J, et al. 2002. Preliminary screening of the inhibitory effect of food extracts on activation of the aryl hydrocarbon receptor induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biol. Pharm. Bull. 25:272-74
61. Abbott BD, Perdew GH, Birnbaum LS. 1994. Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicol. Appl. Pharmacol. 126:16-25
62. Singh S, Hord N, Perdew GH. 1996. Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of Hela cells in the absence of exogenous ligand. Arch. Biochem. Biophys. 329:47-55
63. Chang C-Y, Puga A. 1998. Constitutive activation of the aromatic hydrocarbon receptor. Molec. Cell. Biol. 18:525-35
64. Peters JM, Wiley LM. 1995. Evidence that murine preimplantation embryos express aryl hydrocarbon receptor. Toxicol. Appl. Pharmacol. 134:214-21
65. Ma Q, Whitlock JP Jr. 1996. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Molec. Cell. Biol. 16:2144-50
66. Weiss C, Kolluri SK, Kiefer F, Gottlicher M. 1996. Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor. Exper. Cell Res. 226:154-63
67. Mufti NA, Shuler ML. 1996. Possible role of arachidonic acid in stress-induced cytochrome P450IA1 activity. Biotechnol. Prog. 12:847-54
68. Sadek CM, Allen-Hoffman BL. 1994. Suspension-mediated induction of hepa-1c1c7 CYP1A-1 expression is dependent on the Ah receptor signal transduction pathway. J. Biol. Chem. 269:31505-9
69. Monk SA, Denison MS, Rice RH. 2001. Transient expression of CYP1A1 in rat epithelial cells cultured in suspension. Arch. Biochem. Biophys. 393:154-62
70. Couroucli XI, Welty SE, Geske RS, Moorthy B. 2002. Regulation of pulmonary and hepatic cytochrome P4501A expression in the rat by hyperoxia: implications for hyperoxic lung injury. Molec. Pharmacol. 61:507-15
71. Okamoto T, Mitsuhashi M, Fujita I, Sindhu RK, Kikkawa Y. 1993. Induction of cytochrome P450 1A1 and 1A2 by hyperoxia. Biochem. Biophys. Res. Commun. 197:878-85
72. Lin TM, Ko K, Moore RW, Buchanan DL, Cooke PS, Peterson RE. 2001. Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed male mice. J. Toxicol. Environ. Health. 64:327-42
73. Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, et al. 2000. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl. Acad. Sci. USA. 97:10442-47
74. Paine AJ, Francis JE. 1980. The induction of benzo[a]pyrene-3-mono-oxygenase by singlet oxygen in liver cell culture is mediated by oxidation products of histidine. Chem. Biol. Int. 30:343-53
75. Paine AJ. 1976. Induction of benzo-[a]pyrene mono-oxygenase in liver cell culture by the photochemical generation of active oxygen species. Biochem. J. 158:109-17
76. Goertz G, Barnstorf W, Winnekendonk G, Bolsten K, Fritsch C, et al. 1996. Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isozymes. Arch. Dermatol. Res. 289:46-51
77. Goertz G, Merk H, Bolsen K, Tsambaos D, Berger H. 1983. Influence of chronic UV-light exposure on hepatic and cutaneous monooxygenases. Experentia 39:385-86
78. Rannug A, Rannug U, Rosenkranz HS, Winqvist L, Westerholm R, et al. 1987. Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J. Biol. Chem. 262:15422-27
79. Helferich W, Denison MS. 1991. Photooxidized products of tryptophan can act as dioxin agonists. Molec. Pharmacol. 40:674-78
80. Wei YD, Rannug U, Rannug A. 1999. UV-induced CYP1A1 gene expression in human cells is mediated by tryptophan Chem. Biol. Interact. 118:127-40
81. Wei YD, Bergander L, Rannug U, Rannug A. 2000. Regulation of CYP1A1 transcription via the metabolism of the tryptophan-derived 6-formylindolo[3,2b]carbazole. Arch. Biochem. Biophys. 383:99-107
82. Rannug U, Rannug A, Sjoberg U, Li H, Westerhold R, Bergman A. 1995. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Curr. Biol. 2:841-45
83. Taylor BL, Zhulin IB. 1999. PAS domains: internal sensors of oxygen, redox potential, and light. Microbiol. Mol. Biol. Rev. 63:479-506
84. Briggs WR, Christie JM, Salomon M. 2001. Phototropins: a new family of flavin-binding blue light receptors in plants. Antioxid. Redox Signal. 3:775-88
85. Gu YZ, Hogenesch JB, Bradfield CA. 2000. The PAS superfamily: sensors of environmental and developmental signals. Ann. Rev. Pharmacol. Toxicol. 40: 519-61
86. rd. 1997. Expression of the human aryl hydrocarbon receptor complex in yeast. Activation of transcription by indole compounds. J. Biol. Chem. 272:32824-29
87. Heath-Pagliuso S, Rogers WJ, Tullis K, Seidel SD, Cenijn PH, et al. 1998. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 37:11508-15
88. Heath-Pagliuso S, Mui R, Milici A, Giese S, Chin R, Denison MS. 2000. Tryptophan metabolites, indole-3-pyrivic acid, DL-3-indolelactic acid, L-kynurenine and kynurenic acid activate Ah receptor signal transduction. Organohal. Compd. 49: 289-92
89. van Nguyen T, Paterson IA, Juorio AV, Greenshaw AJ, Boulton AA. 1989. Tryptamine receptors: neurochemical and electrophysiological evidence for postsynaptic and functional binding sites. Brain Res. 476:85-93
90. Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, et al. 2001. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 276:31475-78
91. rd. 1999. A human aryl hydrocarbon receptor signaling pathway constructed in yeast displays additive responses to ligand mixtures. Toxicol. Appl. Pharmacol. 160:297-303
92. Gillam EM, Aguinaldo AM, Notley LM, Kim D, Mundkowski RG, et al. 1999. Formation of indigo by recombinant mammalian cytochrome P450. Biochem. Biophys. Res. Commun. 265:469-72
93. Gillam EM, Notley LM, Cai H, De Voss JJ, Guengerich FP. 2000. Oxidation of indole by cytochrome P450 enzymes. Biochemistry 39:13817-24
94. Blanz J, Ehninger G, Zeller KP. 1989. The isolation and identification of indigo and indirubin from urine of a patient with leukemia. Res. Commun. Chem. Path. Pharmacol. 64:145-56
95. Jackson AH, Jenkins RT, Grinstein M, Ferramola de Sancovich AM, Sancovich HA. 1988. The isolation and identification of indigoid pigments from urine. Clin. Chim. Acta 172:245-52
96. Hahn ME, Chandran K. 1996. Uroporphyrin accumulation associated with cytochrome P4501A induction in fish hepatoma cells exposed to aryl hydrocarbon receptor agonists, including 2,3,7,8-tetrachlorodibenzo-p-dioxin and planar chlorobiphenyls. Arch. Biochem. Biophys. 329:163-74
97. De Matteis F, Marks GS. 1996. Cytochrome P450 and its interactions with the heme biosynthetic pathway. Can. J. Physiol. Pharmacol. 74:741-48
98. Smith AG, Clothier B, Carthew P, Childs NL, Sinclair PR, et al. 2001. Protection of the Cypla2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 173: 89-98
99. Kapitulnik J, Gonzalez FJ. 1993. Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Molec. Pharmacol. 43:722-25
100. Sinal CJ, Bend JR. 1997. Aryl hydrocarbon receptor-dependent induction of cyplal by bilirubin in mouse hepatoma hepa 1c1c7 cells. Molec. Pharmacol. 52:590-99
101. Phelan D, Winter GM, Rogers WJ, Lam JC, Denison MS. 1998. Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch. Biochem. Biophys. 357:155-63
102. Zaccaro C, Sweitzer S, Pipino S, Gorman N, Sinclair PR, et al. 2001. Role of cytochrome P450 1A2 in bilirubin degradation Studies in Cyp1a2(-/-) mutant mice. Biochem. Pharmacol. 61:843-49
103. De Matteis F, Dawson SJ, Boobis AR, Comoglio A. 1991. Inducible bilirubin-degrading system of rat liver microsomes: role of cytochrome P450IA1. Molec. Pharmacol. 40:686-91
104. Kapitulnik J, Gonzalez FJ. 1992. The role of cytochrome P450 in the elimination of bilirubin in congenital jaundice (Crigler-Najjar syndrome type I). J. Basic Clin. Physiol. Pharmacol. 3:90-91
105. Odell GB, Mogilevsky WS, Smith PB, Fenselau C. 1991. Identification of glutathione conjugates of the dimethyl ester of bilirubin in the bile of Gunn rats. Molec. Pharmacol. 40:597-605
106. McDougal A, Gupta MS, Morrow D, Ramamoorthy K, Lee JF, Safe SH. 2001. Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats. Breast Can. Res. Treat. 66:147-57
107. Mohammadpour H, Murray WJ, Stohs SJ. 1988. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced lipid peroxidation in genetically responsive and nonresponsive mice. Arch. Environ. Contam. Toxicol. 17:645-50
108. Alsharif NZ, Grandjean CJ, Murray WJ, Stohs SJ. 1990. 2,3,7,8-Tetrachloro-dibenzo-p-dioxin (TCDD)-induced decrease in the fluidity of rat liver membranes. Xenobiotica 20:979-88
109. al-Bayati ZA, Stohs SJ. 1991. The possible role of phospholipase A2 in hepatic microsomal lipid peroxidation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Arch. Environ. Contam. Toxicol. 20:361-65
110. Tithof PK, Schiamherg E, Peters-Golden M, Ganey PE. 1996. Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls. Environ. Health Perspect. 104:52-58
111. Lawrence BP, Kerkvliet NI. 1998. Role of altered arachidonic acid metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57B1/6 mice Toxicol. Sci. 42:13-22
112. Vecchini F, Mace K, Magdalou J, Mahe Y, Bernard BA, Shroot B. 1995. Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytes. Br. J. Dermatol. 132:14-21
113. Lee CA, Lawrence BP, Kerkvliet NI, Rifkind AB. 1998. 2,3,7,8-Tetrachloro-dibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes: evidence for species-specific differences in responses. Toxicol. Appl. Pharmacol. 153:1-11
114. Inouye K, Mae T, Kondo S, Ohkawa H. 1999. Inhibitory effects of vitamin A and vitamin K on rat cytochrome P4501A1-dependent monooxygenase activity. Biochem. Biophys. Res. Commun. 262:565-69
115. Kramer S, Arthur K, Denison MS, Smith WL, DeWitt DL. 1996. Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8-tetra-chlorodibenzo-p-dioxin. Arch. Biochem. Biophys. 330:319-28
116. Puga A, Hoffer A, Zhou S, Bohm JM, Leikauf GD, Shertzer HG. 1997. Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem. Pharmacol. 54:1287-96
117. Quilley CP, Rifkind AB. 1986. Prostaglandin release by the chick embryo heart is increased by 2,3,7,8-tetrachlo-rodibenzo-p-dioxin and by other cytochrome P-448 inducers. Biochem. Biophys. Res. Commun. 136:582-89
118. Schaldach CM, Riby J, Bjeldanes LF. 1999. Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 38:7594-600
119. Seidel SD, Winters GM, Rogers WJ, Ziccardi MH, Li V, et al. 2001. Activation of the Ah receptor signaling pathway by prostaglandins. J. Biochem. Molec. Toxicol. 15:187-96
120. Serhan CN, Sheppard K-A. 1990. Lipoxin formation during human neutrophil-platelet interactions: evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J. Clin. Invest. 85:772-80
121. Smith WL. 1989. The eicosanoids and their biochemical mechanism of action Biochem. J. 259:315-24
122. Bito LZ, Baroody RA. 1975. Impermeability of rabbit erythrocytes to prostaglandins. Am. J. Physiol. 229:1580-84
123. Schuster VL. 1998. Molecular mechanisms of prostaglandin transport. Annu. Rev. Physiol. 60:221-42
124. Neuschafer-Rabe F, Puschel G, Jungermann K. 1993. Characterization of prostaglandin F2 alpha binding sites on rat hepatocyte plasma membrane. Eur. J. Biochem. 211:163-69
125. Long WP, Pray-Grant M, Tsai JC, Perdew GH. 1998. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Molec. Pharmacol. 53:691-700
126. Chen YH, Tukey RH. 1996. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J. Biol. Chem. 271:26261-66
127. Gradelet S, Astorg P, Pineau T, Canivenc MC, Siess MH, et al. 1997. Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and beta-apo-8′-carotenal, with no affinity for the TCDD binding site. Biochem. Pharmacol. 54:307-15
128. Astorg P, Gradelet S, Leclerc J, Canivenc MC, Siess MH. 1994. Effects of beta-carotene and canthaxanthin on liver xenobiotic-metabolizing enzymes in the rat. Food Chem. Toxicol. 32:735-42
129. McSorley LC, Daly AK. 2000. Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation. Biochem. Pharmacol. 60:517-26
130. Huang DY, Ohnishi T, Jiang H, Furukawa A, Ichikawa Y. 1999. Inhibition by retinoids of benzo(A)pyrene metabolism catalyzed by 3-methylcholanthrene-induced rat cytochrome P-450 1A1. Metabolism 48:689-92
131. Lampen A, Meyer S, Arnhold T, Nau H. 2000. Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes. J. Pharmacol. Exp. Ther. 295:979-85
132. Fletcher N, Hanberg A, Hakansson H. 2001. Hepatic vitamin A depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species. Toxicol. Sci. 62:166-75.
133. Andreola F, Fernandez-Salguero PM, Chiantore MV, Petkovich MP, Gonzalez FJ, De Luca LM. 1997. Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 57:2835-38
134. Jurima-Romet M, Neigh S, Casley WL. 1997. Induction of cytochrome P450 3A by retinoids in rat hepatocyte culture. Hum. Exp. Toxicol. 16:198-203
135. Vecchini F, Lenoir-Viale MC, Cathelineau C, Magdalou J, Bernard BA, Shroot B. 1994. Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene. Biochem. Biophys. Res. Commun. 201:1205-12
136. Soprano DR, Gambone CJ, Sheikh SN, Gabriel JL, Chandraratna RA, et al. 2001. The synthetic retinoid AGN 193109 but not retinoic acid elevates CYP1A1 levels in mouse embryos and Hepa-1c1c7 cells. Toxicol. Appl. Pharmacol. 174:153-59
137. Gambone CJ, Hutcheson JM, Gabriel JL, Beard RL, Chandraratna RA, et al. 2002. Unique property of some synthetic retinoids: activation of the aryl hydrocarbon receptor pathway. Mol. Pharmacol. 61:334-42
138. Bertazzi PA, Bemucci I, Brambilla G, Consonni D, Pesatori AC. 1998. The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ. Health Perspect. 106(Suppl. 2):625-33
139. Cheung MO, Gilbert EF, Peterson RE. 1981. Cardiovascular teratogenicity of 2, 3,7,8-tetrachlorodibenzo-p-dioxin in the chick embryo. Toxicol. Appl. Pharmacol. 61:197-204
140. Vena J, Boffetta P, Becher H, Benn T, Bueno-de-Mesquita HB, et al. 1998. Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ. Health Perspect. 106(Suppl. 2):645-53
141. Heid SE, Walker MK, Swanson HI. 2001. Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci. 61:187-96
142. Savouret JF, Antenos M, Quesne M, Xu J, Milgrom E, Casper RF. 2001. 7-ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor. J. Biol. Chem. 276:3054-59
143. Bradfield CA, Kende AS, Poland A. 1988. Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin. Molec. Pharmacol. 34:229-37
144. Ledirac N, Delesculse C, de Sousa G, Pralavorio M, Lesca P, et al. 1997. Carbaryl induces CYP1A1 gene expression in HepG2 and HaCaT cells but is not a ligand of the human hepatic Ah receptor. Toxicol. Appl. Pharmacol. 144:177-82
145. Sandoz C, Lesca P, Narbonne JF, Carpy A. 2000. Molecular characteristics of carbaryl, a CYP1A1 gene inducer. Arch. Biochem. Biophys. 373:275-80
146. Denison MS, Phelan D, Winter MG, Ziccardi MH. 1998. Carbaryl, a carbamate insecticide, is a ligand for the hepatic Ah (dioxin) receptor. Toxicol. Appl. Pharmacol. 152:406-14
147. Denison MS, Winters, GM, Lam JL, Phelan DM. 1999. Oraeprazole and related benzimidazoles are Ah receptor ligands. Toxicologist 48:304
148. Daujat M, Peryt B, Lesca P, Fourtanier G, Domergue J, Maurel P. 1992. Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor. Biochem. Biophys. Res. Comm. 188:820-25
149. Gillner M, Bergman J, Cambillau C, Fernstrom B, Gustafsson JA. 1985. Interactions of indoles with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol. Pharmacol. 28:357-63
150. Lesca P, Peryt B, Larrieu G, Alvinerie M, Galtier P, et al. 1995. Evidence for the ligand-independent activation of the Ah receptor. Biochem. Biophys. Res. Comm. 209:474-82
151. O'Malley BW, Schrader WT, Mani S, Smith C, Weigel NL, et al. 1995. An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog. Horm. Res. 50:333-47
152. Weigel NL, Zhang Y. 1998. Ligand-independent activation of steroid hormone receptors. J. Molec. Med. 76:469-79
153. Kliewer SA, Lehmann JM, Milburn MV, Willson TM. 1999. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways. Recent Prog. Horm. Res. 54:345-68
154. Corton JC, Anderson SP, Stauber A. 2000. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40:491-518
155. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, et al. 2000. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol. 14:27-39
156. Watkins RE, Noble SM, Redinbo MR. 2002. Structural insights into the promiscuity and function of the human pregnane X receptor. Curr. Opin. Drug Discov. Devel. 5:150-58
157. Owens IS, Nebert DW. 1975. Aryl hydrocarbon hydroxylase induction in mammalian liver-derived cell cultures. Stimulation of "cytochrome P1-450-associated" enzyme activity by many inducing compounds. Molec. Pharmacol. 11:94-104
158. Seidel SD, Li V, Winter GM, Rogers WJ, Martinez EI, Denison MS. 2000. Ah receptor-based chemical screening bioassays: application and limitations for the detection of Ah receptor agonists. Toxicol. Sci. 55:107-15
159. Garrison PM, Aarts JMMJG, Brouwer A, Giesy JP, Denison MS. 1996. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Fund. Appl. Toxicol. 30:194-203
160. Banner CD, Gottlicher M, Widmark E, Sjovall J, Rafter JJ, Gustafsson J-A. 1993. A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: characterization of peroxisome proliferator-activated receptor activators in plasma. J. Lipid Res. 34:1583-91
161. Procopio M, Lahm A, Tramontano A, Pitea D. 2002. A model for recognition of polychlorinated dibenzo-p-dioxins by the aryl hydrocarbon receptor. Eur. J. Biochem. 269:13-18
162. Aix L, Rey-Grobellet X, Larrieu G, Lesca P, Galtier P. 1994. Thiabendazole is an inducer of cytochrome P4501a1 in cultured rabbit hepatocytes. Biochem. Biophys. Res. Comm. 202:1483-89
163. Gleizes-Escala C, Lesca P, Larrieu G, Dupuy J, Pineau T, Galtier P. 1996. Effect of exposure of rabbit hepatocytes to sulfur-containing anthelmintics (oxfendazole and fenbendazole) on cytochrome P4501A1 expression. Toxicol. In Vitro 10:129-39
164. Jeong HG, Lee SS, Kim HK, Yang KH. 1997. Murine Cyp1a-1 induction in mouse hepatoma Hepa-1c1c7 cells by myristicin. Biochem. Biophys. Res. Commun. 233:619-22
165. Marcus CB, Wilson NM, Jefcoate CR, Wilkinson CF, Omiecinski CJ. 1990. Selective induction of cytochrome P450 isozymes in rat liver by 4-n-alkyl-methy-lenedioxybenzenes. Arch. Biochem. Biophys. 277:8-16
166. Puga A, Raychaudhuri B, Nebert DW. 1992. Transcriptional derepression of the murine Cyp1a-1 gene by mevinolin. FASEB J. 6:777-85
167. Boyd GW, Coombs MM, Ioannides C. 1995. CYP1 induction, binding to the hepatic aromatic hydrocarbon receptor and mutagenicity of a series of 11-alkoxy cyclopenta[a]phenanthren-17-ones: a structure activity relationship. Toxicology 95:27-35
168. Fontaine F, Delescluse C, de Sousa G, Lesca P, Rahmani R. 1998. Cytochrome 1A1 induction by primaquine in human hepatocytes and HepG2 cells: absence of binding to the aryl hydrocarbon receptor. Biochem. Pharmacol. 57:255-62
169. Goasduff T, Dreano Y, Guillois B, Menez JF, Berthou F. 1996. Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem. Pharmacol. 52:1915-19
170. Delescluse C, Ledirac N, de Sousa G, Pralavorio M, Lesca P, Rahmani R. 1998. Cytotoxic effects and induction of cytochromes P450 1A1/2 by insecticides, in hepatic or epidermal cells: binding capability to the Ah receptor. Toxicol. Lett. 96/97:33-39
171. Daujat M, Charrasse S, Fabre I, Lesca P, Jounaidi Y, et al. 1996. Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 differentiation. Eur. J. Biochem. 237:642-52
172. Iba MM, Scholl H, Fung J, Thomas PE, Alam J. 1998. Induction of pulmonary CYP1A1 by nicotine. Xenobiotica 28:827-43
173. Kim H, Reddy S, Hovak RF. 1995. 3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue. Drug Metab. Dispos. 23:818-24